We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Effects of combination estrogen plus progestin hormone treatment on cognition and affect
Authors
Resnick, Susan M.Maki, Pauline M.
Rapp, Stephen R.
Espeland, Mark A.
Brunner, Robert L.
Coker, Laura H.
Granek, Iris A.
Hogan, Patricia
Ockene, Judith K.
Shumaker, Sally A.
UMass Chan Affiliations
Department of Medicine, Division of Preventive and Behavioral MedicineDocument Type
Journal ArticlePublication Date
2006-03-07Keywords
AffectAged
Cognition
Depression
Estrogen Replacement Therapy
Estrogens
Estrogens, Conjugated (USP)
Female
Humans
Longitudinal Studies
Medroxyprogesterone 17-Acetate
Memory
Middle Aged
Neuropsychological Tests
Progesterone Congeners
Life Sciences
Medicine and Health Sciences
Women's Studies
Metadata
Show full item recordAbstract
CONTEXT: Some studies of hormone treatment in postmenopausal women suggest benefits on specific cognitive functions, particularly memory. OBJECTIVE: The objective of this study was to determine whether hormone therapy influences changes in specific cognitive functions and affect in older women. DESIGN: This study was a randomized, double-blind, placebo-controlled clinical trial. SETTING: Participants were women from 14 of 40 clinical centers of the Women's Health Initiative (WHI). PARTICIPANTS: Postmenopausal women (1416) aged 65 yr and older, free of probable dementia, and enrolled in WHI and the WHI Memory Study (WHIMS) trial of combination estrogen and progestin for a mean of 3 yr and followed for a mean of 1.35 yr, were studied. INTERVENTION: Intervention was conjugated equine estrogen (CEE; 0.625 mg) with 2.5 mg medroxyprogesterone acetate (MPA) in one daily tablet (CEE + MPA) or placebo. MAIN OUTCOME MEASURES: Annual rates of change in specific cognitive functions and affect, adjusted for time since randomization, were measured. RESULTS: CEE + MPA had a negative impact on verbal memory (PCONCLUSIONS: The effect of CEE + MPA on cognitive function varies across cognitive domains in older women, reflecting both possible beneficial and detrimental actions of ovarian steroids on the aging brain. Our results extend prior findings about dementia and global cognitive function to age-related changes in specific cognitive functions and suggest directions for future research.Source
J Clin Endocrinol Metab. 2006 May;91(5):1802-10. Epub 2006 Mar 7. Link to article on publisher's siteDOI
10.1210/jc.2005-2097Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50910PubMed ID
16522699Related Resources
Link to article in PubMedae974a485f413a2113503eed53cd6c53
10.1210/jc.2005-2097